LON:GCL Geiger Counter (GCL) Share Price, News & Analysis GBX 73 +0.50 (+0.69%) As of 12:33 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsBuy This Stock About Geiger Counter Stock (LON:GCL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Geiger Counter alerts:Sign Up Key Stats Today's Range 70.22▼ 7350-Day Range 64▼ 79.7352-Week Range 35.30▼ 92Volume387,126 shsAverage Volume545,987 shsMarket Capitalization£83.28 millionP/E Ratio6.01Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview A closed-end investment company investing in the exploration, development and production of uranium for nuclear energy. Read More Receive GCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Geiger Counter and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GCL Stock News HeadlinesGeiger Counter repurchases 210,000 shares at 47.62 pence eachJuly 23, 2025 | investing.comGeiger Counter buys back 52,841 shares at 43.69 pence eachJuly 4, 2025 | investing.comI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.May 14 at 1:00 AM | Brownstone Research (Ad)Geiger Counter buys back 600,000 shares at 44.09 pence eachJune 23, 2025 | investing.comGeiger Counter Ltd buys back 1 million sharesJune 6, 2025 | investing.comGeiger Counter Ltd announces share buybackMay 30, 2025 | investing.comGeiger Counter Ltd executes share buybackMay 19, 2025 | investing.comGeiger Counter Limited executes share buybackMay 16, 2025 | investing.comSee More Headlines GCL Stock Analysis - Frequently Asked Questions How have GCL shares performed this year? Geiger Counter's stock was trading at GBX 58.70 at the beginning of the year. Since then, GCL shares have increased by 24.4% and is now trading at GBX 73. How were Geiger Counter's earnings last quarter? Geiger Counter (LON:GCL) posted its quarterly earnings data on Monday, December, 29th. The company reported ($1.43) earnings per share (EPS) for the quarter. Geiger Counter had a net margin of 147.84% and a trailing twelve-month return on equity of 27.19%. How do I buy shares of Geiger Counter? Shares of GCL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Geiger Counter own? Based on aggregate information from My MarketBeat watchlists, some other companies that Geiger Counter investors own include Mason Resources (LLG), JPMorgan Equity Premium Income ETF (JEPI), CureVac (CVAC), Novavax (NVAX), Company Calendar Last Earnings12/29/2025Today5/14/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:GCL CIKN/A Webwww.ncim.co.uk Phone+44-1534-825200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)GBX 12.14 Trailing P/E Ratio6.01 Forward P/E RatioN/A P/E GrowthN/ANet Income-£11.70 million Net Margins147.84% Pretax MarginN/A Return on Equity27.19% Return on Assets28.68% Debt Debt-to-Equity Ratio12.82 Current RatioN/A Quick Ratio0.00 Sales & Book Value Annual Sales£18.48 million Price / Sales4.51 Cash FlowGBX 0.19 per share Price / Cash Flow390.00 Book ValueGBX 54.81 per share Price / Book1.33Miscellaneous Outstanding Shares114,080,000Free FloatN/AMarket Cap£83.28 million OptionableNot Optionable Beta0.62 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (LON:GCL) was last updated on 5/14/2026 by MarketBeat.com Staff. From Our PartnersBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...Equiscreen | SponsoredPeptide Company Lands Exclusive MMA Wellness PartnershipA publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...The Tomorrow Investor | SponsoredThis is the worst news for stocks in 50 yearsGoldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...TradeSmith | SponsoredThe system holding the dollar together is gone…Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...Golden Portfolio | SponsoredMillionaire warns: Move your money before May 15Larry Benedict - the trader who generated $274 million in client profits and beat the S&P 500 by 18 times in 2...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geiger Counter Please log in to your account or sign up in order to add this asset to your watchlist. Share Geiger Counter With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
